ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Q32 Bio Inc

Q32 Bio Inc (QTTB)

3.21
-0.02
( -0.62% )
Updated: 11:18:07

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
3.21
Bid
3.20
Ask
3.22
Volume
100,688
3.16 Day's Range 3.29
3.02 52 Week Range 53.79
Previous Close
3.23
Open
3.29
Last Trade
70
@
3.2199
Last Trade Time
11:18:07
Average Volume (3m)
294,254
Financial Volume
$ 323,367
VWAP
3.2116

QTTB Latest News

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024

Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 PR Newswire WALTHAM, Mass., Oct. 14...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.29-8.285714285713.53.773.026744343.35944995CS
4-23.64-88.044692737426.8528.663.027186646.41316337CS
12-41.68-92.849186901344.8953.173.0229425414.33427752CS
26-12.34-79.356913183315.5553.793.0219509321.11202948CS
52-13.03-80.233990147816.2453.793.0214720221.44406893CS
156-13.03-80.233990147816.2453.793.0214720221.44406893CS
260-13.03-80.233990147816.2453.793.0214720221.44406893CS

QTTB - Frequently Asked Questions (FAQ)

What is the current Q32 Bio share price?
The current share price of Q32 Bio is $ 3.21
What is the 1 year trading range for Q32 Bio share price?
Q32 Bio has traded in the range of $ 3.02 to $ 53.79 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BAOSBaosheng Media Group Holdings Ltd
$ 8.69
(402.31%)
49M
HOURHour Loop Inc
$ 5.0991
(256.58%)
64.76M
AVGRAvinger Inc
$ 1.75
(172.42%)
85.35M
CREVCarbon Revolution Public Ltd
$ 9.56
(145.76%)
23.28M
GTIGraphjet Technology
$ 0.504399
(122.20%)
75.4M
SLGLSol Gel Technologies Ltd
$ 0.95
(-42.42%)
2.36M
CHEKCheck Cap Ltd
$ 1.43
(-36.44%)
2.52M
RENBRenovaro Inc
$ 0.76359
(-31.82%)
2.46M
BTFValkyrie ETF Trust II CoinShares Bitcoin and Ether Stratagy ETF
$ 15.4008
(-30.69%)
109.64k
PYPDPolyPid Ltd
$ 2.70
(-26.63%)
166.81k
SVMHSRIVARU Holding Ltd
$ 0.03225
(15.18%)
256.01M
LITMSnow Lake Resources Ltd
$ 0.5826
(52.23%)
133.08M
AVGRAvinger Inc
$ 1.75
(172.42%)
85.35M
RGTIRigetti Computing Inc
$ 12.1898
(11.22%)
76.35M
GTIGraphjet Technology
$ 0.504399
(122.20%)
75.4M

Your Recent History

Delayed Upgrade Clock